Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neonatal/infantile-onset self-limited familial syndrome characterized by the presence of febrile seizures in an individual with a family history of seizures/epilepsy. Febrile seizures may be typical febrile seizures or 'febrile seizures plus' (FS+) may occur, where febrile seizures continue past 6 years of age and/or are accompanied by afebrile seizures which may be generalized or focal. FS+ and GEFS+ are distinguished on the basis of family history. A number of dominantly inherited genes have been linked to both GEFS+ and FS+, with implications for specific genetic counselling, due to the variable severity of the epilepsy in different family members. Although febrile seizures are the hallmark of this familial syndrome, not all individuals in a family may have these.
No clinical trials have been registered for genetic epilepsy with febrile seizures plus spectrum.
106 publications have been identified in PubMed for genetic epilepsy with febrile seizures plus spectrum. Kisho has analyzed 38 by research type. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (32%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 13 | 34% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:07 PM UTC
Laboratory research |
12 |
32% |
Disease patterns and progression | 6 | 16% |
Patient case studies | 5 | 13% |
New treatment approaches | 2 | 5% |
Li XL (2026). [PMID: 41788412](https://pubmed.ncbi.nlm.nih.gov/41788412/). *Front Genet*. [Case Report / Case Series]
Kissling L (2026). [PMID: 42127217](https://pubmed.ncbi.nlm.nih.gov/42127217/). *Sci Transl Med*. [Basic Science / Preclinical]
Millevert C (2026). [PMID: 40472023](https://pubmed.ncbi.nlm.nih.gov/40472023/). *Brain*. [Basic Science / Preclinical]
Wang Y (2026). [PMID: 42037703](https://pubmed.ncbi.nlm.nih.gov/42037703/). *Front Neurol*. [Case Report / Case Series]
Mishra YG (2026). [PMID: 42131109](https://pubmed.ncbi.nlm.nih.gov/42131109/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Muhammad A (2026). [PMID: 42046183](https://pubmed.ncbi.nlm.nih.gov/42046183/). *Mol Genet Genomic Med*. [Review / Meta-Analysis]
Dell'Isola GB (2026). [PMID: 41739881](https://pubmed.ncbi.nlm.nih.gov/41739881/). *Epilepsia Open*. [Epidemiology / Natural History]
Pentz R (2025). [PMID: 40120363](https://pubmed.ncbi.nlm.nih.gov/40120363/). *Seizure*. [Case Report / Case Series]
Akiba T (2025). [PMID: 40811894](https://pubmed.ncbi.nlm.nih.gov/40811894/). *Seizure*. [Case Report / Case Series]
Qi Y (2025). [PMID: 40126693](https://pubmed.ncbi.nlm.nih.gov/40126693/). *Cell Mol Life Sci*. [Basic Science / Preclinical]